Ignite Creation Date:
2024-05-06 @ 5:38 PM
Last Modification Date:
2024-10-26 @ 2:32 PM
Study NCT ID:
NCT05378646
Status:
COMPLETED
Last Update Posted:
2022-05-18
First Post:
2022-04-20
Brief Title:
Efficiency and Safety of the Drug Ingaron Interferon-gamma Human Recombinant in the Treatment of Chronic Prostatitis
Sponsor:
SPP Pharmaclon Ltd
Organization:
SPP Pharmaclon Ltd
Organization Data
Organization:
SPP Pharmaclon Ltd
Class:
INDUSTRY
Study ID:
ING-HP-1
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
SPP Pharmaclon Ltd
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None